A Decadal Exploration of Cutaneous Adverse Effects of FDA-Approved Cardiovascular Medications: Insights From 2013 to 2023
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Cardiovascular Pharmacology"
DOI: 10.1097/fjc.0000000000001660
Abstract: Abstract: Given the high prevalence of cardiovascular disease in the United States, there is a critical need for new medications to improve the outcomes of these diseases. The US Food and Drug Administration has approved… read more here.
Keywords: exploration cutaneous; cutaneous adverse; cardiovascular medications; 2013 2023 ... See more keywords